source
- Experts hail new pancreatic cancer drug daraxonrasib as biggest breakthrough in decadesA conference in London brought together international pancreatic cancer researchers to discuss the latest advances. The meeting quickly shifted focus when a new drug, daraxonrasib, was highlighted…
- Agenus redirects late-stage colorectal trial to pre-surgery setting, shares double; Oxford Ebola vaccine enters Phase 1Agenus announced it will stop financially supporting its late-stage trial of the BOT+BAL immunotherapy combination in late-line colorectal cancer. The company will instead use recent $340 million…